Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

News
India, Once America’s Counterweight to China, Is Now Facing Trump’s Wrath

With threats of tariffs up to 50 percent, President Trump seems to be scrapping America’s plan to turn India into a counterweight to China, declaring instead that it is a “dead economy.”

News
Trump Demands That Drugmakers Lower Some of Their U.S. Prices by September

The administration has not put forward a clear legal authority to compel drugmakers to reduce their prices.

News
Study Suggests Weight-Loss Pill is as Effective as Ozempic

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.

News
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.

News
Sybil Shainwald, Lawyer Who Fought for Women’s Health, Dies at 96

After taking part in a landmark case against the manufacturers of the synthetic hormone DES, she represented many other victims of harmful drugs and devices.

News
What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

News
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

News
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.

News
Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.

News